UK government has extended its deal with Wockhardt Ltd for packaging of covid-19 vaccines by six months, the Indian drugmaker said in a statement on Wednesday.The company had in August last year entered into an 18-month agreement with the UK Government to fill finish covid-19 vaccines manufactured in the country.The fill-finish of vaccines, which is filling doses into vials, would be undertaken at CP Pharmaceuticals, a subsidiary of Wockhardt based at Wrexham in North Wales.The agreement is now expanded to August 2022, and Wockhardt will continue to package vaccine vials at its unit in Wrexham in Wales, the company said."By extending our contract with Wockhardt, we will ensure the UK has uninterrupted fill and finish capacity, guaranteeing.